Status:
COMPLETED
Health of Pessary Versus Progesterone Supplement for Preventing Preterm Birth Children
Lead Sponsor:
Mỹ Đức Hospital
Conditions:
Preterm Birth
Eligibility:
All Genders
1-66 years
Brief Summary
To give strong recommendations on the efficacy and safety of vaginal progesterone versus cervical cerclage, we conduct this study to investigate the physical and mental development of children from va...
Detailed Description
Preterm birth (PB) is the leading cause of neonatal morbidity and mortality. Twin pregnancies and short cervical length are two high-risk factors of PB. Generally, in singleton pregnancies with short ...
Eligibility Criteria
Inclusion
- Live babies born from The pessary versus vaginal progesterone in women with a twin pregnancy and a cervix \<38 mm study (NCT02623881)
- Parents agree to participate in the study.
Exclusion
- Babies died after the perinatal period.
Key Trial Info
Start Date :
March 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 9 2020
Estimated Enrollment :
529 Patients enrolled
Trial Details
Trial ID
NCT04295187
Start Date
March 6 2020
End Date
December 9 2020
Last Update
February 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mỹ Đức Hospital
Ho Chi Minh City, Vietnam